首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1347567

分子診斷市場：2023-2028 年全球行業趨勢、佔有率、規模、成長、機遇和預測

Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年09月04日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

市場概況：

2022年全球分子診斷市場規模達到185億美元。展望未來，IMARC Group預計到2028年市場規模將達到274億美元，2023-2028年年複合成長率（CAGR）為6.5%。

分子診斷是指對個體的脫氧核糖核酸 (DNA)、核糖核酸 (RNA) 或細胞蛋白進行測序以分析潛在疾病的生物標記的一組實驗室測試。它有助於診斷和監測感染和疾病、檢測風險以及評估治療反應。近年來，分子診斷在腫瘤學、藥物基因組學、微生物學、傳染病、遺傳病篩查和血液篩查等領域迅速受到關注。隨著最近的進步，分子診斷已成為針對患者的干涉和治療的重要方面，這正在全球範圍內不斷增加其需求。

分子診斷市場趨勢：

分子診斷廣泛應用於醫院、實驗室和研究機構，用於疾病的早期檢測、凝血和人類白細胞抗原分型。因此，癌症、心血管疾病（CVD）、神經系統疾病和傳染病等慢性病患病率的上升是推動市場成長的主要因素。除此之外，越來越多的老年人口更容易患上多種醫療疾病，以及現場護理 (POC) 測試設備的廣泛採用，正在刺激產品需求。此外，最近爆發的冠狀病毒病 (COVID-19) 加速了分子診斷方法的採用，例如聚合酶鏈反應 (PCR)，用於 COVID-19 檢測。與此同時，各國管理機構和監管機構採取的多項有利舉措，例如快速批准診斷產品以幫助遏制病毒傳播，也推動了市場成長。此外，領先企業正在投入巨資推出創新的診斷設備，這些設備可提供更高的準確性、靈活性、成本效益和更快的結果，以擴大其產品組合併獲得競爭優勢。其他因素，包括個性化治療需求的不斷成長、預防醫學的新興趨勢、醫療基礎設施的改善和技術進步，也創造了積極的市場前景。

本報告回答的關鍵問題：

迄今為止，全球分子診斷市場表現如何，未來幾年將如何表現？
COVID-19 對全球分子診斷市場有何影響？
主要區域市場有哪些？
基於產品的市場細分是什麼？
基於技術的市場細分是什麼？
基於應用程式的市場細分是什麼？
基於最終用戶的市場細分是什麼？
行業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球分子診斷市場的結構如何？誰是主要參與者？
行業競爭程度如何？

北美
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳大利亞
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- Agilent Technologies Inc.
- Becton Dickinson and Company
- Biomerieux SA
- Danaher Corporation
- Diasorin Molecular LLC (DiaSorin SpA)
- F. Hoffmann-La Roche AG (Roche Holding AG)
- Hologic Inc.
- Illumina Inc.
- Myriad Genetics Inc.
- Qiagen
- Quidel Corporation
- Thermo Fisher Scientific

簡介目錄圖表

Product Code: SR112023A5726

Market Overview:

The global molecular diagnostics market size reached US$ 18.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.

Molecular diagnostics refers to a set of laboratory tests that sequences the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or cell proteins of an individual to analyze biomarkers of potential diseases. It assists in diagnosing and monitoring infections and diseases, detecting risks, and assessing therapy response. In recent years, molecular diagnostics has rapidly gained traction in oncology, pharmacogenomics, microbiology, infectious diseases, genetic disease screening, and blood screening. With recent advancements, molecular diagnostics has become an essential aspect of patient-tailored interventions and therapeutics, which is escalating its demand across the globe.

Molecular Diagnostics Market Trends:

Molecular diagnostics is widely used by hospitals, laboratories, and research institutes for early detection of diseases, coagulation, and human leukocyte antigen typing. As a result, the rising prevalence of chronic conditions, such as cancer, cardiovascular diseases (CVDs), neurological disorders, and infectious diseases, represents the primary factor driving the market growth. Besides this, the growing geriatric population that is more susceptible to developing numerous medical ailments and the widespread adoption of point-of-care (POC) testing devices are catalyzing the product demand. Additionally, the recent outbreak of coronavirus disease (COVID-19) has accelerated the adoption of molecular diagnostic methods, such as polymerase chain reaction (PCR), for COVID-19 testing. Along with this, several favorable initiatives undertaken by the governing agencies and regulatory authorities of various countries, such as fast approvals of diagnostic products to help curb the spread of the virus, are also propelling the market growth. Furthermore, the leading players are making heavy investments to launch innovative diagnostic devices that offer enhanced accuracy, flexibility, cost-effectiveness, and faster results to expand their product portfolio and gain a competitive edge. Other factors, including the escalating demand for personalized treatment, the emerging trend of preventive medicine, improving healthcare infrastructure, and technological advancements, are also creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end users.

Breakup by Product:

Reagents and Kits

Instruments

Software and Services

Breakup by Technology:

Polymerase Chain Reactions (PCR)

Hybridization

DNA Sequencing

Microarray

Isothermal Nucleic Acid Amplification Technology (INAAT)

Others

Breakup by Application:

Infectious Diseases Diagnostics

Oncology

Genetic Testing

Blood Screening

Others

Breakup by End Users:

Hospitals

Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific.

Key Questions Answered in This Report:

How has the global molecular diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global molecular diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end users?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global molecular diagnostics market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Molecular Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Reagents and Kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Polymerase Chain Reactions (PCR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Hybridization
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 DNA Sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Microarray
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Infectious Diseases Diagnostics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Oncology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Genetic Testing
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Blood Screening
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End Users

9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Agilent Technologies Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Becton Dickinson and Company
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Biomerieux SA
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Danaher Corporation
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Diasorin Molecular LLC (DiaSorin S.p.A.)
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 F. Hoffmann-La Roche AG (Roche Holding AG)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 SWOT Analysis
- 15.3.8 Hologic Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Illumina Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Myriad Genetics Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Qiagen
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Quidel Corporation
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis
- 15.3.13 Thermo Fisher Scientific
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio
  - 15.3.13.3 Financials
  - 15.3.13.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2022
Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2022
Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2022
Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2022
Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2022
Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2022
Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million US$), 2023-2028
Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Molecular Diagnostics Market: Competitive Structure
Table 8: Global: Molecular Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219